Jarrett Jennifer
- SEC CIK
- 0001671311
In the past year, 3 open-market sale filings worth $2.17M and no purchases.
Current role at each company
- ZURA Zura Bio LtdDirectoras of Jun 22, 2026
- SGMT Sagimet Biosciences Inc.Directoras of Jun 15, 2026
- DMRA Damora Therapeutics, Inc.See Remarksas of Apr 1, 2026
- SNDX Syndax Pharmaceuticals IncDirectoras of Feb 6, 2026
- RCUS Arcus Biosciences, Inc.Chief Operating Officeras of Jan 26, 2026
Show 3 more companies
- Radius Health, Inc.Directoras of Aug 15, 2022
- ARNA Arena Pharmaceuticals IncDirectoras of Mar 11, 2022
- SRZN Surrozen, Inc.Other: Former Directoras of Aug 13, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.17M
- 3 filings
- Net
- −$2.17M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jarrett Jennifer as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RCUS Arcus Biosciences, Inc.
Chief Operating Officer20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing) | Dec 16-17 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −21.2K | $22.01 | −$466.8K | −9.9%193.0K after | 2 lots10b5-1 |
| Nov 12, 2025 (view filing) | Nov 7 | 5 days | Jarrett JenniferChief Operating Officer | SSale | −50.3K | $18.97 | −$954.0K | −19.0%214.2K after | 10b5-1 |
| Oct 8, 2025 (view filing) | Oct 6-8 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −50.3K | $14.92 | −$750.5K | −19.0%214.2K after | 2 lots10b5-1 |
| Mar 29, 2024 (view filing) | Mar 27 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −11.6K | $17.55 | −$202.7K | −5.1%215.3K after | 10b5-1 |
| Mar 20, 2024 (view filing) | Mar 18 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −13.4K | $17.92 | −$240.9K | −5.6%226.8K after | 2 lots10b5-1 |
| Feb 28, 2024 (view filing) | Feb 26-27 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −58.6K | $20.09 | −$1.18M | −19.6%240.3K after | 2 lots10b5-1 |
| Dec 26, 2023 (view filing) | Dec 22 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −21.5K | $17.76 | −$382.2K | −7.7%258.9K after | 10b5-1 |
| Sep 26, 2023 (view filing) | Sep 22 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −21.4K | $19.99 | −$427.2K | −6.6%302.7K after | 10b5-1 |
| Jul 31, 2023 (view filing) | Jul 28 | 3 days | Jarrett JenniferChief Operating Officer | SSale | −45.0K | $20.25 | −$911.3K | −11.8%336.6K after | 10b5-1 |
| Jun 26, 2023 (view filing) | Jun 22 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −12.4K | $19.12 | −$237.8K | −3.2%381.6K after | 10b5-1 |